|
Market Closed -
Nasdaq
00:00:00 27/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 4.240 USD | +0.95% |
|
+0.71% | +121.99% |
| 08-11 | C4 Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 06-29 | C4 Therapeutics, Inc.(NasdaqGS:CCCC) added to Russell 2000 Index | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 4.265 | 4.67 | 4.37 |
| Spread/Res. | -0.59% | -9.21% | -2.97% |
| Spread/Supp. | +10.70% | +26.19% | +47.22% |
| Support | 3.83 | 3.36 | 2.88 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- CCCC Stock
- Charts C4 Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
